Clearbridge Health Limited (SGX:1H3)
Singapore
· Delayed Price · Currency is SGD 0.0010
0.00 (0.00%)
At close: Apr 27, 2026
Clearbridge Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 9.93 | 9.9 | 10.41 | 16.41 | 11.44 | Upgrade
|
| Revenue Growth (YoY) | 0.26% | -4.84% | -36.59% | 43.44% | -68.44% | Upgrade
|
| Cost of Revenue | 4.87 | 5.12 | 5.28 | 6.84 | 5.08 | Upgrade
|
| Gross Profit | 5.06 | 4.78 | 5.13 | 9.58 | 6.36 | Upgrade
|
| Selling, General & Admin | 4.55 | 5.11 | 5.58 | 6.21 | 6.77 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.01 | 0.01 | 0.01 | 0.06 | 0.11 | Upgrade
|
| Other Operating Expenses | 2.49 | 2.5 | 3.05 | 3.81 | 3.23 | Upgrade
|
| Operating Expenses | 8.21 | 8.77 | 9.82 | 11.58 | 11.74 | Upgrade
|
| Operating Income | -3.15 | -3.99 | -4.69 | -2.01 | -5.38 | Upgrade
|
| Interest Expense | -0.33 | -0.68 | -0.73 | -0.87 | -1.72 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.02 | 0.17 | 0.08 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.33 | 0.13 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.6 | 0.26 | -18.77 | 0.28 | -2.88 | Upgrade
|
| EBT Excluding Unusual Items | -4.4 | -4.26 | -24.02 | -2.52 | -9.93 | Upgrade
|
| Impairment of Goodwill | -8.59 | - | -10.37 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.15 | -8.77 | -6.62 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | - | 0.01 | 0.17 | 2.01 | Upgrade
|
| Asset Writedown | - | - | - | -0.12 | - | Upgrade
|
| Other Unusual Items | - | 0.11 | 0.27 | - | 0.97 | Upgrade
|
| Pretax Income | -12.99 | -4.14 | -34.27 | -11.24 | -13.57 | Upgrade
|
| Income Tax Expense | 0.08 | 0.07 | -1.9 | 0.19 | 0.32 | Upgrade
|
| Earnings From Continuing Operations | -13.07 | -4.21 | -32.37 | -11.43 | -13.89 | Upgrade
|
| Earnings From Discontinued Operations | - | 0.11 | -0.09 | 1.33 | -3.59 | Upgrade
|
| Net Income to Company | -13.07 | -4.1 | -32.47 | -10.09 | -17.48 | Upgrade
|
| Minority Interest in Earnings | 0.16 | 0.49 | 0.27 | -1.05 | -2.49 | Upgrade
|
| Net Income | -12.91 | -3.61 | -32.2 | -11.14 | -19.97 | Upgrade
|
| Net Income to Common | -12.91 | -3.61 | -32.2 | -11.14 | -19.97 | Upgrade
|
| Shares Outstanding (Basic) | 3,290 | 687 | 619 | 618 | 617 | Upgrade
|
| Shares Outstanding (Diluted) | 3,290 | 687 | 619 | 618 | 617 | Upgrade
|
| Shares Change (YoY) | 378.73% | 11.07% | 0.14% | 0.12% | 2.75% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.05 | -0.02 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.05 | -0.02 | -0.03 | Upgrade
|
| Free Cash Flow | -2.81 | -2.08 | -3.99 | -2.66 | -3.74 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | 50.97% | 48.26% | 49.27% | 58.35% | 55.61% | Upgrade
|
| Operating Margin | -31.72% | -40.26% | -45.05% | -12.22% | -47.02% | Upgrade
|
| Profit Margin | -130.00% | -36.43% | -309.40% | -67.90% | -174.53% | Upgrade
|
| Free Cash Flow Margin | -28.26% | -21.04% | -38.34% | -16.18% | -32.68% | Upgrade
|
| EBITDA | -2.98 | -3.76 | -4.36 | -0.34 | -2.37 | Upgrade
|
| EBITDA Margin | -30.05% | -37.97% | -41.90% | -2.10% | -20.67% | Upgrade
|
| D&A For EBITDA | 0.17 | 0.23 | 0.33 | 1.66 | 3.02 | Upgrade
|
| EBIT | -3.15 | -3.99 | -4.69 | -2.01 | -5.38 | Upgrade
|
| EBIT Margin | -31.72% | -40.26% | -45.05% | -12.22% | -47.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.